Bio X Cell社 製品情報

Bio X Cell社とは

Bio X Cell社は高品質なモノクローナル抗体をミリグラムからグラム単位の大容量で製造、販売をしているバイオテクノロジー企業です。同社の抗体製品は高純度かつ低エンドトキシンとなっており、また保存剤や安定剤を添加していないためin vivoでの研究にも最適です。

大学および非営利施設のお客様にはディスカウント価格でご提供しております。
詳しくは弊社までお問い合わせください。

InVivoMab™(抗体製品)▼ターゲット名を選択ください

in vivoおよびin vitro研究に有用な高品質抗体を1mgから安価に提供開始

  • フローサイトメトリーによる品質検証済み
  • Bio X Cell社のみが実現する衝撃価格
  • 提供濃度 4mg/ml ~ 10mg/ml

in vivo研究の厳しい基準を満たした抗体・タンパク質希釈液。

  • 極めて低いエンドトキシン(<0.0005 EU/ug)
  • マウス病原体フリー
  • 毒性についての動物実験検証済み
  • Bio X Cell社抗体製品に適した組成・pH条件
    4種類のpH(6.0, 6.5, 7.0, 8.0)、TWEEN80の含有/不含の計6種類を提供

抗体医薬研究のためのヒトIgGネガティブコントロール

  • 抗体医薬研究のコントロールとして使用可能なヒトIgG1,IgG2モノクローナル抗体です。
  • ヒトIgG抗体開発におけるFc領域由来の非特異的反応の分析に有用です。
  • InVivo研究のほかELISA, WB, IF, IHC, IP, FACSでの使用も可能です。
  • InVivoMab™ とInVivoPlus™ の2種類のグレードをご用意しております。
  • 推奨希釈液はInVivoPure™ pH 7.0 Dilution Bufferです。

● InVivoPlus™(高グレード抗体製品)

エンドトキシン:≦0.001 EU/μg
純度:≧95%
アジ化ナトリウム、キャリアタンパクフリー
マウス病原体フリー
タンパク質凝集物:≦5%
FACS、ELISA法による品質試験済み
容量:5mg, 25mg, 50mg, 100mg
抗原クローンアイソタイプアプリケーション(文献)製品番号
4-1BB(CD137)LOB12.3Rat IgG14-1BB activationBP0169
CD3ε(Mouse)145-2C11Armenian Hamster IgG1DP, T cell stimulation/activation, IF, FC, WBBP0001-1
CD4(Mouse)GK1.5Rat IgG2bDP, FC, WBBP0003-1
CD8α(Mouse)2.43Rat IgG2bDP, WBBP0061
CD8α(Mouse)53-6.7Rat IgG2aDP, IF, FC, WBBP0004-1
CD8α(Mouse)YTS169.4Rat IgG2bDP, WBBP0117
CD25(IL-2Rα)(Mouse)PC-61.5.3Rat IgG1DP, FCBP0012
CD40(Mouse)FGK4.5/FGK45Rat IgG2aCD40 activation, B cell stimulation/activation, DC stimulation/activationBP0016-2
CD40L(CD154)(Mouse)MR-1Armenian Hamster IgGBL, WBBP0017-1
CSF1R (CD115)(Mouse)AFS98Rat IgG2aDP, Neu, FC, WBBP0213
CTLA-4(CD152)(Mouse)UC10-4F10-11Armenian Hamster IgGNeu, FC, WBBP0032
CTLA-4(CD152)(Mouse)9D9Mouse IgG2bNeu, WBBP0164
CTLA-4(CD152)(Mouse)9H10Syrian Hamster IgGNeu, WBBP0131
GITR(Mouse)DTA-1Rat IgG2bGITR stimulationBP0063
IFNAR-1(Mouse)MAR1-5A3Mouse IgG1BL, WBBP0241
IFNγ(Mouse)XMG1.2Rat IgG1Neu, ELISPOT, FC, WBBP0055
IL-4(Mouse)11B11Rat IgG1Neu, FC, WBBP0045
IL-10R(CD210)(Mouse)1B1.3ARat IgG1BL, FC, WBBP0050
IL-12 p40(Mouse)C17.8Rat IgG2aNeu, p40 affinity chromatography, IP, ELISA, FC, WBBP0051
IL-17A(Mouse)17F3Mouse IgG1NeuBP0173
LAG-3(Mouse)C9B7WRat IgG1Neu, FC, WBBP0174
Ly6G(Mouse)1A8Rat IgG2aDP, IF, IHC(P), IHC(Fr), FCBP0075-1
Ly6G/Ly6C(Gr-1)(Mouse)RB6-8C5Rat IgG2bDP, FC, IHC(P), IHC(Fr)BP0075
NK1.1(Mouse)PK136Mouse IgG2aDP, FCBP0036
OX40(CD134)(Mouse)OX-86Rat IgG1OX40 activation, WBBP0031
PD-1(CD279)(Mouse)J43Armenian Hamster IgGBL, Neu, WBBP0033-2
PD-1(CD279)(Mouse) Hot!RMP1-14Rat IgG2aBL, WBBP0146
PD-1(CD279)(Mouse)29F.1A12Rat IgG2aBL, Neu, IHC(Fr), IF, WB, FCBP0273
PD-L1(B7-H1)(Mouse) Hot!10F.9G2Rat IgG2bBL, IF, IHC(Fr), FC, WBBP0101
TGF-β(Mouse / Human / Rat / Monkey / Hamster / Canine / Bovine)1D11.16.8Mouse IgG1Neu, WBBP0057
Thy1.2(CD90.2)(Mouse)30H12Rat IgG2bDP, WBBP0066
TIM-3(CD366)(Mouse)RMT3-23Rat IgG2aNeu, BL, FCBP0115
TNFa(Mouse)XT3.11Rat IgG1Neu, WBBP0058
VEGFR-2(Mouse)DC101Rat IgG1BL, WBBP0060
VISTA(Mouse)13F3Armenian Hamster IgGBL, FCBP0310
【凡例】
  • BL:ブロッキング
  • DP:細胞除去
  • FA:機能解析
  • FC:フローサイトメトリー
  • IF:免疫蛍光染色
  • IHC:免疫染色
  • IP:免疫沈降
  • Neu:中和活性
  • WB:ウエスタンブロット

● InVivoMab™(抗体製品)

エンドトキシン:≦0.002 EU/μg
純度:≧95%
アジ化ナトリウム、キャリアタンパクフリー
容量:1mg, 5mg, 25mg, 50mg, 100mg
抗原クローンアイソタイプアプリケーション(文献)製品番号
2C TCR(Mouse)1B2Mouse IgG1IF, FCBE0069
4-1BB(CD137)(Mouse)LOB12.3Rat IgG14-1BB activationBE0169
4-1BB(CD137)(Mouse)3H3Rat IgG2a4-1BB stimulationBE0239
4-1BB(CD137)(Mouse)17B5Syrian Hamster IgGBL, FCBE0296
4-1BBL(CD137L)(Mouse)TKS-1Rat IgG2aBLBE0110
AChR(Human/Rat/Fish)Mab35(TIB-175)Rat IgG1EAMG induction in rats, IFBE0123
B220(Mouse)RA3.3A1/6.1(TIB-146)Rat IgMDP, B cell negative selectionBE0067
β-2-Microglobulin(Rat)4C9Mouse IgG1-BE0143
CD80(B7-1)(Mouse)1G10Rat IgG2aBL, Affinity chromatographyBE0134
BTLA(CD272)(Mouse)6A6Armenian Hamster IgGBTLA stimulation, BLBE0132
BTLA(CD272)(Mouse)PK18.6Rat IgG1κBTLA stimulation, FCBE0153
BTLA(CD272)(Mouse)PJ196Mouse IgG1BL,  T cell stimulation/activation, FCBE0196
BTLA(CD272)(Mouse)8F4Mouse IgG1FCBE0210
BTLA(CD272)(Mouse)6F7Mouse IgG1κDP, FCBE0304
CCL2(MCP-1)(Human/Mouse/Rat)2H5Armenian Hamster IgGNeu, IHC(Fr)BE0185
CCR3 (CD193)(Mouse)6S2-19-4Rat IgG2b, λDPBE0316
CD1a(Human)OKT-6Mouse IgG1BL, FCBE0211
CD1d(CD1.1)(Mouse)19G11Rat IgG1NeuBE0000
CD1d(CD1.1)(Mouse)20H2(HB323)Rat IgG1Neu, BL, FCBE0179
CD3(Human)OKT-3Mouse IgG2aT cell stimulation/activation/inhibition for xenografts, DP, BL, FCBE0001-2
CD3(Human)UCHT1(Leu-4)(T3)Mouse IgG1DP, ex vivo T cell inhibition for xenographs, FCBE0231
CD3(Mouse)17A2Rat IgG2bT cell stimulation/activationBE0002
CD3ε(Mouse)145-2C11Armenian Hamster IgG1DP,  T cell stimulation/activation, IF, FC, WBBE0001-1
CD3ε F(ab')2 fragment(Mouse)145-2C11Armenian Hamster IgG1DPBE0001-1FAB
CD3ε(Mouse)KT3Rat IgG2aT cell negative selection,  T cell stimulation/activation, IFBE0261
CD4(Human)OKT-4Mouse IgG2bT cell stimulation/activation, DP, FC, IPBE0003-2
CD4(Human)RPA-T4Mouse IgG1BL, IF, IHC(Fr), FCBE0288
CD4(Mouse) Hot!GK1.5Rat IgG2bDP, FC, WBBE0003-1
CD4(Mouse)YTS 177Rat IgG2aBLBE0003-3
CD4(Mouse)YTS 191Rat IgG2bDPBE0119
CD4(Rat)OX-38Rat IgG2aκDP, FCBE0308
CD8(Lyt2.1)(Mouse)116-13.1(HB129)Mouse IgG2aDP, FCBE0118
CD8α(Human)OKT-8Mouse IgG2aDPBE0004-2
CD8α(Mouse)53-6.7Rat IgG2aDP, IF, FC, WBBE0004-1
CD8α(Mouse) Hot!2.43Rat IgG2bDP, WBBE0061
CD8α(Mouse)YTS169.4Rat IgG2bDP, WBBE0117
CD8β(Lyt3.2)(Mouse)53-5.8Rat IgG1DP, BL, IFBE0223
CD11a(LFA-1α)(Human)R7-1Mouse IgG1FA, FCBE0192
LFA-1α(CD11a)(Human)TS-1/22.1.1.13Mouse IgG1NeuBE0005
LFA-1α(CD11a)(Mouse)FD441.8Rat IgG2bNeuBE0005-1
LFA-1α(CD11a)(Mouse)M17/4Rat IgG2aNeu, FCBE0006
CD11b(Mouse/Human)M1/70Rat IgG2bNeu, ILC2 cell purification, FCBE0007
CD16/32(Mouse)2.4G2Rat IgG2bκBLBE0307
CD18(Mouse)M18/2Rat IgG2aNeuBE0009
CD19(Human)4G7Mouse IgG1FC, FA, IF, Chimeric antigen receptor constructionBE0281
CD19(Mouse)1D3Rat IgG2aDP, Neu, B cell negative selection, FCBE0150
CD20(Human/Monkey)2H7Mouse IgG2bDP, IHC(Fr), IP, FCBE0276
CD20(Mouse)AISB12Rat IgG2aDP, FC, WBBE0302
CD22(Mouse)Cy34.1Mouse IgG1DP, FC, IPBE0011
CD25(IL-2Rα)(Human)7G7B6Mouse IgG2aIP, IFBE0014
CD25(IL-2Rα)(Mouse)PC-61.5.3Rat IgG1DP, FCBE0012
CD28(Human)9.3Mouse IgG2aT cell stimulation/activationBE0248
CD28(Human/Monkey)CD28.2Mouse IgG1T cell stimulation/activation, FC, IHC(Fr)BE0291
CD28(Mouse)37.51Syrian Hamster IgG2T cell stimulation/activation, BLBE0015-1
CD28(Mouse)PV-1Armenian Hamster IgGT cell stimulation/activationBE0015-5
CD28(Mouse)D665Mouse IgG1, κT cell stimulation/activationBE0328
CD28(Rat)JJ319Mouse IgG1T cell stimulation/activation, FCBE0040
CD29(Mouse)KMI6Rat IgG2aIF, FCBE0232
CD32(FcgRIIA)(Human)IV.3Mouse IgG2bBL, ELISA, FCBE0224
CD38(Mouse)NIMR5Rat IgG2a, κCD38 stimulation, B cell stimulation, IF, ELISA, FCBE0317
CD40(Human)G28.5Mouse IgG1B cell stimulation, macrophage stimulation, FA, FCBE0189
CD40(Mouse) Hot!FGK4.5/FGK45Rat IgG2aCD40 activation,  B cell stimulation/activation,  DC stimulation/activationBE0016-2
CD40L(CD154)(Mouse)MR-1Armenian Hamster IgGBL, WBBE0017-1
CD40L (CD154) (Human/Monkey)5C8Mouse IgG2aBL, IP, FCBE0292
CD44(Human)Hermes-1Rat IgG2aBL, WB, IFBE0262
CD44(Mouse/Human)IM7Rat IgG2bNeuBE0039
CD45.2(Mouse)104.2Mouse IgG2aκFC, BL, IHC(Fr)BE0300
CD45RB(Mouse)MB23G2(HB220)Rat IgG2aanti-CD45RB-mediated tolerance induction, DPBE0019
CD47(Human)B6.H12Mouse IgG1Neu, FCBE0019-1
CD47(Human/Mouse/Rat)MIAP410Mouse IgG1BL, IFBE0283
CD47(IAP)(Mouse)MIAP301Rat IgG2aBL, IFBE0270
CD48(Mouse)HM48-1Armenian Hamster IgGBLBE0147
CD54(ICAM-1)(Human)R6-5-D6Mouse IgG2aT cell stimulation/activation, IFBE0020-2
CD54(ICAM-1)(Mouse)YN1/1.7.4Rat IgG2bNeu, IHC(Fr), ELISABE0020-1
CD69(Mouse)CD69.2.2Mouse IgG1, κin vivo down-regulation of CD69 expression, FABE0330
CD70(Mouse)FR70Rat IgG2bBL, FCBE0022
CD71(Human)OKT-9Mouse IgG1FC, IHC(Fr)BE0023
CD71(TfR1)(Mouse)R17 217.1.3/TIB-219Rat IgG2aDPBE0175
CD71(TfR1)(Mouse)8D3Rat IgG2aDP, IF, IHC(Fr), WBBE0329
CD71(TfR1)(Rat/Mouse)OX-26Mouse IgG2a, κTargeted drug delivery to the brain, IHC(Fr), FCBE0331
CD73(Mouse)TY/23Rat IgG2aBLBE0209
CD80(B7-1)(Mouse)16-10A1Armenian Hamster IgG2BL, FCBE0024
CD80(B7-1)(Rat)3H5Mouse IgG1BL, FCBE0187
CD86(B7-2)(Mouse)GL-1Rat IgG2aBL, FCBE0025
CD103(Mouse)M290Rat IgG2aNeu, IF, FCBE0026
CD106(VCAM-1)(Mouse)M/K-2.7Rat IgG1Neu, IFBE0027
CD122(IL-2Rβ)(Mouse)5H4Rat IgG2aNK cell negative selection, IP, FCBE0272
CD122(IL-2Rβ)(Mouse)TM-Beta 1Rat IgG2bNK cell depletion, BL, FA, FCBE0298
CD132(common γ chain)(Mouse)3E12Rat IgG2bBL, FA, IP, FCBE0271
CD172a (SIRPα)(Mouse)P84Rat IgG1, κBL, WB, IP, FCBE0322
CD200(OX2)(Mouse)OX-90Rat IgG2aκBL, IHC(Fr), IF, FCBE0299
CD209b(SIGN-R1)(Mouse)22D1Armenian Hamster IgGBL, IHC(Fr), WB, FCBE0220
CD276(B7-H3)(Mouse)MJ18Rat IgG1BL, FCBE0124
CD317 (BST2, PDCA-1)(Mouse)927Rat IgG2b, κDP, IF, FCBE0311
c-Kit(CD117)(Mouse)2B8Rat IgG2bFC, IF, IHCBE0280
CLEC9A (CD370)(Mouse)7H11Rat IgG1κin vivo Ag targeting to CLEC9A+ DCs, WB, ELISA, IP, IF, FCBE0305
c-myc(Human)9E10Mouse IgG1WB, ELISA, IP, FCBE0238
denatured collagen type-I (RGD motif)(Human/Mouse)XL313Mouse IgG1, κWB, IF, in vivo administrationBE0324
CSF1(Mouse)5A1Rat IgG1NeuBE0204
CSF1R(CD115)(Mouse) Hot!AFS98Rat IgG2aDP, Neu, FC, WBBE0213
CTLA-4(CD152)(Human)BN13Mouse IgG2aNeu, FCBE0190
CTLA-4(CD152)(Mouse)UC10-4F10-11Armenian Hamster IgGNeu, FC, WBBE0032
CTLA-4(CD152)(Mouse) Hot!9H10Syrian Hamster IgGNeu, WBBE0131
CTLA-4(CD152)(Mouse) Hot!9D9Mouse IgG2bNeu, WBBE0164
CXCL9(MIG)(Mouse)MIG-2F5.5Armenian Hamster IgG, κIFBE0309
CXCR3(CD183)(Mouse)CXCR3-173Armenian Hamster IgGNeu, FCBE0249
Delta-like protein1(DLL1)(Mouse)HMD1-5Armenian Hamster IgGNeu, FCBE0155
Delta-like protein4(DLL4)(Mouse)HMD4-2Armenian Hamster IgGNeuBE0127
DR5(CD262)(Mouse)MD5-1Armenian Hamster IgGinduction TRAIL-mediated apoptosisBE0161
EGFR(Human)225Mouse IgG1BL, WB, FABE0278
EGFR(Human)528Mouse IgG2aBL, WB, FA, IP, IHC(P), IF, FCBE0279
E-Selectin(Human)CL2Mouse IgG2aFCBE0136
E-selectin (CD62E)(Mouse)9A9Rat IgG2bBL, IHC(Fr)BE0294
F4/80(Mouse)CI:A3-1Rat IgG2bDP, FA, IHC(P), IHC(Fr), FCBE0206
FasL (CD178)(Mouse)MFL3Armenian Hamster IgGBL, FA, ELISA, FCBE0319
FcRn heavy chain heterodimers(Rat)2G3Mouse IgG1ELISA, FC, IHC(P), FCBE0144
FcRn heavy chain heterodimers1G3Mouse IgG1IF, ELISA, FCBE0222
FGL-1(Mouse)177R4Rat IgG2a, κBL, FC, IHC(P)BE0332
Galectin-9(Mouse)RG9-1Rat IgG2bBLBE0218
Ganglioside GD2(Human)14G2aMouse IgG2a, κin vitro induction of apoptosis in GD2+ cells,
in vivo inhibition of GD2+ tumor cell growth
BE0318
GITR(Mouse)DTA-1Rat IgG2bGITR stimulationBE0063
Glycophorin A(type M)(Human)6A7MMouse IgG1-BE0162
GM-CSF(Mouse)MP1-22E9Rat IgG2aNeu, FCBE0259
HER2(neu)(Human/Rat)7.16.4Mouse IgG2aHER2/neu inhibition, IP, IF, FCBE0277
HIV gp12055-36Mouse IgG1-BE0154
ICOS(Mouse)7E.17G9Rat IgG2bBL, FCBE0059
ICOSL(CD275)(Mouse)HK5.3Rat IgG2aNeuBE0028
IFNAR-1(Mouse) Hot!MAR1-5A3Mouse IgG1BL, WBBE0241
IFNγ(Human)B133.5Mouse IgG1NeuBE0235
IFNγ(Human)B27Mouse IgG1FCBE0245
IFNγ(Mouse)R4-6A2Rat IgG1NeuBE0054
IFNγ(Mouse)XMG1.2Rat IgG1Neu, ELISPOT, FC, WBBE0055
IFNγ(Mouse)H22Armenian Hamster IgGNeuBE0312
IFNγR(CD119)(Mouse)GR-20Rat IgG2aNeuBE0029
IFNγRα(CD119)(Mouse)2E2Armenian Hamster IgGWB, IP, FCBE0287
IgG1(Rat)RG11/39.4Mouse IgG2aFCBE0250
IgG2a(Rat)RG7/1.30Mouse IgG2bIF, ELISA, FCBE0251
IgG2b(Rat)RG7/11.1Mouse IgG2bELISA, FCBE0252
IL-1α(Mouse)ALF-161Armenian Hamster IgGNeuBE0243
IL-1β(Mouse/Rat)B122Armenian Hamster IgGNeu, ELISABE0246
IL-1R(CD121a)(Mouse)JAMA-147Armenian Hamster IgGBLBE0256
IL-2(Mouse)JES6-5H4Rat IgG2bNeu, IL-2 receptor stimulation, ELISPOT, FCBE0042
IL-2(Mouse)S4B6-1Rat IgG2aNeu, IL-2 receptor stimulationBE0043-1
IL-2(Mouse)JES6-1A12Rat IgG2aNeu, IL-2 receptor stimulationBE0043
IL-3(Mouse)MP2-8F8Rat IgG1Neu, IL-3 receptor stimulation, ELISA, FCBE0282
IL-4(Human)MP4-25D2Rat IgG1Neu, FCBE0240
IL-4(Mouse)11B11Rat IgG1Neu, FC, WBBE0045
IL-4(Mouse)BVD6-24G2Rat IgG1ELISA, ELISPOT, FCBE0199
IL-5(Mouse/Human)TRFK5Rat IgG1Neu, DPBE0198
IL-6(Mouse)MP5-20F3Rat IgG1NeuBE0046
IL-6R(Mouse)15A7Rat IgG2bBLBE0047
IL-7(Mouse/Human)(as a complex with IL-7)M25Mouse IgG2bNeu, IL-7 receptor stimulationBE0048
IL-7Rα(CD127)(Mouse)A7R34Rat IgG2aBL, FCBE0065
IL-9(Mouse)9C1Mouse IgG2aNeuBE0181
IL-9(HUman)MH9A4Mouse IgG2b, κFC, ELISABE0327
IL-10(Mouse)JES5-2A5Rat IgG1NeuBE0049
IL-10R(CD210)(Mouse)1B1.3ARat IgG1BL, FC, WBBE0050
IL-12(Mouse)R1-5D9Rat IgG2aNeuBE0052
IL-12 p40(Mouse)C17.8Rat IgG2aNeu, p40 affinity chromatography, IP, ELISA, FCBE0051
IL-12 p70(Human)20C2Rat IgG1FA, ELISA, FCBE0234
IL-12 p75(Mouse)R2-9A5Rat IgG2bNeu, ELISABE0233
IL-15(Mouse)AIO.3Rat IgG2a, λNeuBE0315
IL-17A(Mouse)17F3Mouse IgG1NeuBE0173
IL-17F(Mouse)MM17F8F5.1A9Mouse IgG1, κNeuBE0303
IL-18(Mouse)YIGIF74-1G7Rat IgG2aNeuBE0237
IL-21R(Mouse)4A9Rat IgG2aBLBE0258
IL-23(p19)(Mouse)G23-8Rat IgG1, κNeu, WBBE0313
IL-27 p28(Mouse)MM27.7B1Mouse IgG2a, κNeu, FCBE0326
Influenza A virus NPH16-L10-4R5(HB65)Mouse IgG2aIP, IHC(P), induction of passive immunity to influenza A virusBE0159
Integrin β7(Mouse/Human)FIB504Rat IgG2aIP, WB, FCBE0062
Jagged 2(Mouse)HMJ2-1Armenian Hamster IgGNeuBE0125
Kappa Immunoglobulin Light Chain(Rat)MAR 18.5Mouse IgG2aDPBE0122
Kappa Immunoglobulin Light Chain(Mouse)187.1(HB58)Rat IgG1IFBE0176
KLRG-1(Mouse/Human)2F1Syrian Hamster IgGFCBE0201
LAG-3(Mouse)C9B7WRat IgG1Neu, FC, WBBE0174
LCMV nucleoproteinVL-4Rat IgG2aIF, FCBE0106
LPAM-1(Integrin α4β7)(Mouse)DATK32Rat IgG2aNeu, FCBE0034
LRP1(CD91)(Mouse / Human / Rat)11H4Mouse IgG1, κWB, IF, IPBE0333
L-Selectin(CD62L)(Mouse)Mel-14Rat IgG2aNeuBE0021
Ly6C(Mouse)Monts 1Rat IgG2aDP, FCBE0203
Ly6G(Mouse) Hot!1A8Rat IgG2aDP, IF, IHC(P), IHC(Fr), FCBE0075-1
Ly6G/Ly6C(Mouse)NIMP-R14Rat IgG2b, κDP, IHC(P), IHC(Fr), IF, FCBE0320
Ly6G/Ly6C(Gr-1)(Mouse)RB6-8C5Rat IgG2bDP, FC, IHC(P), IHC(Fr)BE0075
MAdCAM-1(Mouse)MECA-367Rat IgG2aNeu, IFBE0035
MHC Class I(H-2)(Mouse)M1/42.3.9.8Rat IgG2aBL, IF, FCBE0077
MHC Class I(H-2Kb)(Mouse)AF6-88.5.5.3Mouse IgG2aadministration, FCBE0121
MHC Class I(H-2Kb)(Mouse)Y-3Mouse IgG2bFA, Purification of MHC peptide complexes, FCBE0172
MHC Class I(H-2Kb) bound to SIINFEKL peptide(OVA residues 257-264)(Mouse)25-D1.16Mouse IgG1FA, FCBE0207
MHC Class I(H-2Kd)(Mouse)SF1.1.10(HB159)Mouse IgG2aPurification of MHC peptide complexes, FCBE0104
MHC Class I(H-2Kd,H-2Dd)(Mouse)34-1-2SMouse IgG2aactivation of APCsBE0180
MHC Class I(H-2Kk)(Mouse)AF3-12.1.3Mouse IgG1administrationBE0152
MHC Class I(H-2Kk,H-2Dk)(Mouse)15-3-1S(HB13)Mouse IgG2aadministration, FCBE0158
MHC Class I(H-2Kk,H-2Dk)(Mouse)16-1-2N(HB14)Mouse IgG2aFA, FCBE0228
MHC Class I(HLA-A,HLA-B,HLA-C)(Human)W6/32Mouse IgG2aFABE0079
MHC Class I(SLAd)(Swine)74-11-10(HB139)Mouse IgG2bFCBE0120
MHC class II (HLA-DR)(Human/Monkey)L243Mouse IgG2aκBL, WB, FC, binding assay, negative selectionBE0306
MHC Class II(βchain)(Mouse)KL277Hamster/Mouse IgGWBBE0140
MHC Class II(I-A)(Mouse)Y-3PMouse IgG2aBL, FCBE0178
MHC Class II(I-A/I-E)(Mouse)M5/114Rat IgG2bBL, FA, IF, FC, IP, WBBE0108
MHC Class II(I-Ak,I-Ar,I-Af,I-As,I-Ag7)(Mouse)10-3.6.2Mouse IgG2aMHC class II I-A BL, MHC class II I-A expressing cell negative selectionBE0068
MHC Class II(I-Ek/RT1-D)(Mouse/Rat)14-4-4S(HB32)Mouse IgG2aBL, FCBE0167
NK1.1(Mouse) Hot!PK136Mouse IgG2aDP, FCBE0036
NKG2A/C/E(Mouse)20D5Rat IgG2a, κBL, IHC(Fr), FCBE0321
NKG2D(Mouse)HMG2DArmenian Hamster IgGBLBE0111
NKG2D(CD314)(Mouse)CX5Rat IgG1, κBL, FCBE0334
Nonclassical MHC Class I molecule Qa-1b(Mouse)4C2.4A7.5H11Mouse IgG1WB, IFBE0165
Notch 4(Mouse)HMN4-14Armenian Hamster IgGNotch4 stimulation, FCBE0129
OX40(CD134)(Mouse)OX-86Rat IgG1OX40 activation, WBBE0031
OX40L(CD134L)(Mouse)RM134LRat IgG2bBL, NeuBE0033-1
Pan-endothelial Cell Antigen(MECA-32)(Mouse)MECA-32Rat IgG2aIHC(Fr), FC, WB, IFBE0200
PD-1(CD279)(Human)J116Mouse IgG1Neu, BLBE0188
PD-1(CD279)(Human)J110Mouse IgG1FCBE0193
PD-1(CD279)(Mouse)J43Armenian Hamster IgGBL, Neu, WBBE0033-2
PD-1(CD279)(Mouse) Hot!RMP1-14Rat IgG2aBL, WBBE0146
PD-1(CD279)(Mouse) Hot!29F.1A12Rat IgG2aBL, Neu, IHC(Fr), IF, WB, FCBE0273
PD-L1(B7-H1)(Human)29E.2A3Mouse IgG2bBL, FA, IHC(Fr), FCBE0285
PD-L1(B7-H1)(Mouse) Hot!10F.9G2Rat IgG2bBL, IF, IHC(Fr), FC, WBBE0101
PD-L2(B7-DC)(Mouse)TY25Rat IgG2aBL, IHC(Fr), FCBE0112
Phosphotyrosine4G10Mouse IgG2bELISA, WBBE0194
Podoplanin(gp38)(Mouse)8.1.1Syrian Hamster IgGBL, IF, WB, FCBE0236
PSGL-1(CD162)(Mouse)4RA10Rat IgG1BL, IHC(Fr)BE0186
RANKL(CD254)(Mouse)IK22/5Rat IgG2aBLBE0191
Siglec-H(Mouse)440cRat IgG2badministration, FCBE0202
T15VH and T15VL regions of IgM(Mouse)AB1-2(HB33)Mouse IgG1ELISABE0072
TCR Vγ1.1/Cr4(Mouse)2.11Armenian Hamster IgGFCBE0257
TCRβ(Mouse)H57-597(HB218)Armenian Hamster IgGDPBE0102
TCRγ/δ(Mouse)UC7-13D5Armenian Hamster IgGNeu, γ/δ T cell stimulation,γ/δ T cell purification, FA, IP, FCBE0070
Ter-119(Mouse)TER-119Rat IgG2badministration, FA, FCBE0183
TGF-β(Mouse / Human / Rat / Monkey / Hamster / Canine / Bovine)1D11.16.8Mouse IgG1Neu, WBBE0057
Thy1(CD90)(Mouse)M5/49.4.1Rat IgG2aDPBE0076
Thy1(CD90)(Mouse)T24/31Rat IgG2bDPBE0212
Thy1.1(CD90.1)(Mouse)19E12Mouse IgG2aDPBE0214
Thy1.2(CD90.2)(Mouse)30H12Rat IgG2bDP, WBBE0066
TIGIT(Mouse)1G9Mouse IgG1BL, FCBE0274
TIM-1 (CD365) (Mouse)RMT1-10Rat IgG2aNeuBE0113
TIM-1 (CD365) (Mouse)3B3Rat IgG2aTIM-1 activation, T cell stimulation/activation, FA, ELISA, FCBE0289
TIM-1 (CD365) (Mouse)3D10Rat IgG1, κBLBE0314
TIM-2(Mouse)RMT2-29Rat Ig2a, λ-BE0114
TIM-3(CD366)(Mouse)RMT3-23Rat IgG2aNeu, BL, FCBE0115
TIM-3(CD366)(Mouse)B8.2C12Rat IgG1Neu, BL, FCBE0275
TIM-4(Mouse)RMT4-53Rat IgG2b, κBL, IFBE0171
TIM-4(Mouse)RMT4-54Rat IgG2aBL, IF, FCBE0225
TL1A(TNFSF15)(Mouse)5G4.6Armenian Hamster IgGNeu FCBE0323
TNFα(Mouse)XT3.11Rat IgG1Neu, WBBE0058
TNFα(Mouse/Rat/Rabbit)TN3-19.12Armenian Hamster IgGNeu, FCBE0244
TNFR2(CD120b)(Mouse)TR75-54.7Armenian Hamster IgGBLBE0247
TYRP1/TRP1(gp75)(Mouse/Human)TA99Mouse IgG2atriggering of FcγRs, IF, FCBE0151
Vβ4 TCR(Mouse)KT4Rat IgG2badministration, FCBE0166
Vβ8 TCR(Mouse)F23.1Mouse IgG2aFCBE0182
VEGFR-2(Mouse)DC101Rat IgG1BL, WBBE0060
Vγ2 TCR(Mouse)UC3-10A6Armenian Hamster IgGDP, FCBE0168
v-H-Ras(Mouse/Human/Rat)Y13-238Rat IgG2aIPBE0139
VISTA(Mouse)13F3Armenian Hamster IgGBL, FCBE0310
VLA-4(CD49d)(Mouse/Human)PS/2Rat IgG2bNeu, FCBE0071
West Nile/dengue virus E proteinE60Mouse IgG2a, κNeuBE0325
YB-1(Human)21A3Mouse IgG1IHC(P), WBBE0216
【凡例】
  • BL:ブロッキング
  • DP:細胞除去
  • FA:機能解析
  • FC:フローサイトメトリー
  • IF:免疫蛍光染色
  • IHC:免疫染色
  • IP:免疫沈降
  • Neu:中和活性
  • WB:ウエスタンブロット

● アイソタイプコントロール製品

容量:1mg(InVivoMabのみ), 5mg, 25mg, 50mg, 100mg
BE0091-FAB: 5mg, 10mg, 25mg, 50mg
製品名クローン製品番号
Human IgG1 Isotype control, InVivoPlus™N/ABP0297
Human IgG1 Isotype control, InVivoMab™N/ABE0297
Human IgG2 Isotype control, InVivoPlus™N/ABP0301
Human IgG2 Isotype control, InVivoMab™N/ABE0301
Human IgG, InVivoMab™PolyclonalBE0092
Mouse IgG1 Isotype control; Unknown Specificity, InVivoPlus™MOPC-21BP0083
Mouse IgG1 Isotype control; Unknown Specificity, InVivoMab™ Hot!MOPC-21BE0083
Mouse IgG2a Isotype control; Unknown Specificity, InVivoPlus™C1.18.4BP0085
Mouse IgG2a Isotype control; Unknown Specificity, InVivoMab™ Hot!C1.18.4BE0085
Mouse IgG2b Isotype control; Unknown Specificity, InVivoPlus™MPC-11BP0086
Mouse IgG2b Isotype control; Unknown Specificity, InVivoMab™MPC-11BE0086
Mouse IgG, InVivoMab™PolyclonalBE0093
Rat IgG1 Isotype control; anti Horseradish Peroxidase, InVivoPlus™HRPNBP0088
Rat IgG1 Isotype control; anti Horseradish Peroxidase, InVivoMab™HRPNBE0088
Rat IgG1 Isotype control; anti Trinitrophenol, InVivoPlus™TNP6A7BP0290
Rat IgG1 Isotype control; anti Trinitrophenol, InVivoMab™TNP6A7BE0290
Rat IgG2a Isotype control; anti Trinitrophenol, InVivoPlus™ Hot!2A3BP0089
Rat IgG2a Isotype control; anti Trinitrophenol, InVivoMab™ Hot!2A3BE0089
Rat IgG2b Isotype control; anti KLH, InVivoPlus™LTF-2BP0090
Rat IgG2b Isotype control; anti KLH, InVivoMab™ Hot!LTF-2BE0090
Rat IgG, InVivoMab™PolyclonalBE0094
Goat IgG, InVivoMab™PolyclonalBE0130
Armenian Hamster IgG Isotype Control; anti glutathione S-transferase, InVivoMab™PIPBE0260
Armenian Hamster IgG, InVivoPlus™PolyclonalBP0091
Armenian Hamster IgG, InVivoMab™ Hot!PolyclonalBE0091
Armenian Hamster IgG f(ab')2 Fragments, InVivoMab™PolyclonalBE0091-FAB
Syrian Hamster IgG, InVivoPlus™PolyclonalBP0087
Syrian Hamster IgG, InVivoMab™PolyclonalBE0087
Rabbit IgG, InVivoMab™PolyclonalBE0095

● InVivoPure™(抗体・タンパク質希釈液)

製品名製品番号容量
InVivoPure pH 6.5 Dilution BufferIP006550ml
InVivoPure pH 7.0 Dilution BufferIP007050ml
InVivoPure pH 8.0 Dilution BufferIP008050ml
InVivoPure pH 6.0T Dilution BufferIPT06050ml
InVivoPure pH 6.5T Dilution BufferIPT06550ml
InVivoPure pH 8.0T Dilution BufferIPT08050ml

● ReadyTag™(抗タグ抗体製品)

容量:1mg, 5mg, 10mg, 25mg
抗原クローンアイソタイプアプリケーション(文献)製品番号
c-myc9E10Mouse IgG1WB, ELISA, IP, FCRT0263
GSTF50-3D12.2Mouse IgG1WBRT0264
GFPF56-6A1.2.3Mouse IgG2bWB, IFRT0265
6-His6-HisMouse IgG1WB, IP, IFRT0266
OVAF2-3.58Mouse IgG1ELISART0267
HA12CA5Mouse IgG2bELISA, WB, IP, IFRT0268
DDDDKAP1501Mouse IgG2bWB, IP, IFRT0269

● 融合タンパク質製品

製品名製品番号容量
Recombinant CTLA-4-Ig (hum/hum), InVivoPlus™BP00995mg, 25mg, 50mg, 100mg
Recombinant CTLA-4-Ig (hum/hum)BE00995mg, 25mg, 50mg, 100mg
Recombinant Human IgG1 FcBE00965mg, 25mg, 50mg, 100mg
Recombinant Mouse IgG2a FcBE00975mg, 25mg, 50mg, 100mg

● モノクローナル抗体受託製造サービス

Bio X Cell社ではモノクロ抗体製造の為の細胞培養と精製の受託サービスを提供しております。
撹拌槽型バイオリアクターやWAVEバイオリアクターを用いた最先端の培養技術を採用しており、
製造スケールは5Lから500Lまで対応しております。
詳しくはこちらをご覧ください。

資料請求・製品に関するお問合せは弊社企画開発課まで

企画開発課 [TEL] 03-3241-2573 [FAX] 03-3279-6397

本ページに掲載の商品は全て研究用試薬です。研究目的以外の用途にはご使用できません。また、個人の方への販売は行っておりません。